PS-OCT: a promising new diagnostic tool for RPE diseases

Article

Polarisation-sensitive optical coherence tomography (PS-OCT) is a promising new tool for diagnosis, disease follow-up and the evaluation of new treatment strategies in disease affecting the retinal pigment epithelium .

Polarization-sensitive optical coherence tomography (PS-OCT) is a promising new tool for diagnosis, disease follow-up and the evaluation of new treatment strategies in disease affecting the retinal pigment epithelium (RPE), according to a study published in the February issue of the British Journal of Ophthalmology.

Stephan Michels and colleagues from the University of Vienna, the Medical University of Vienna, Austria, University Hospital Zurich, Switzerland and Moorfields Eye Hospital, London, UK evaluated pathological changes of retinal pigment epithelium using PS-OCT in 44 eyes (22 patients).

The RPE scrambles the polarization state of backscattered light (i.e. acts as a depolarizing layer), while the polarization state of transmitted light is maintained. In patients with RPE pathologies, irregularity, elevation, thickening or absence of the RPE is readily visualized by exploiting the depolarization information. Polarization scrambling in the sensory retina can be found in cases of advanced dry macular degeneration. Sclera and fibrosis show characteristic birefringence in PS-OCT.

The authors of this study believe that PS-OCT allows tissue identification based on polarization scrambling and birefringence, thus providing additional information on RPE pathologies.

Newsletter

Join ophthalmologists across Europe—sign up for exclusive updates and innovations in surgical techniques and clinical care.

Recent Videos
Christine Curcio, PhD, of the University of Alabama at Birmingham Heersink School of Medicine, shares histology update and revised nomenclature for OCT with Sheryl Stevenson of the Eye Care Network and Ophthalmology Times
SriniVas R. Sadda, MD, FARVO, shares key points from his retina presentation at the International SPECTRALIS Symposium
Robert Sergott, MD, describes fluorescence lifetime imaging ophthalmoscopy (FLIO) and the International SPECTRALIS Symposium – And Beyond (ISS) in Heidelberg, Germany.
Rayaz Malik, MBChB, PhD, a professor of medicine at Weill Cornell Medicine - Qatar, spoke with Ophthalmology Times Europe about his presentation. It's titled "An eye on neurodegenerative diseases: Challenging the dogma" at the International SPECTRALIS Sympsoium. In conversation with Hattie Hayes, Ophthalmology Times Europe
Anat Loewenstein, MD, describes her presentation on remote imaging for age-related macular degeneration and geographic atrophy at the International SPECTRALIS Symposium, in conversation with Hattie Hayes of Ophthalmology Times Europe
Tyson Brunstetter, OD, PhD, a US Navy Aerospace Optometrist at the NASA Johnson Space Center in Houston, Texas, shares key takeaways from his keynote at the International SPECTRALIS Symposium (ISS)
Rayaz Malik, MBChB, PhD, shares his presentation, titled An eye on neurodegenerative diseases: Challenging the dogma, at this year's International SPECTRALIS Symposium
At the Retina World Congress, Siegfried Priglinger, MD, speaks about ensuring the best outcomes for preschool-aged patients
At the 2025 ASCRS meeting, Robert Ang, MD said small aperture IOLs can benefit all patients, especially those with complex corneas or who have undergone previous corneal refractive surgery
Viha Vig, MBChB graduate student at the University of Auckland, New Zealand, discusses her poster presentation on the relationship between mitochondiral disease, Alzheimer disease, and other types of dementia.
© 2025 MJH Life Sciences

All rights reserved.